the efficacy , safety , and tolerance of pentoxifylline ( trental , hoechst-roussel pharmaceuticals , inc. ) in the treatment of intermittent claudication associated with chronic occlusive arterial disease ( coad ) were evaluated in a double-blind , placebo-controlled , parallel-group , multicenter clinical trial involving a total of 128 outpatients .
C0030899
pentoxifylline
C0699487
trental